| ||||||||||||||
|
|
|||||||||||||



Departments of *Anesthesiology, Critical Care, and Emergency, and the
Department of Epidemiology and Biostatistics, University-Hospital of Nîmes, France;
Laboratoire dAnesthésie, UPRES EA 392, Faculté de Médecine, Université Paris Sud, Kremlin Bicêtre, Bicêtre, France; and
the Laboratory of Anesthesiology and Cardiovascular Physiology, Medical School of Montpellier-Nîmes, France
Address correspondence and reprint requests to Professeur Jean E. de La Coussaye, Département dUrgences-Réanimation, CHU Nîmes, 5 Rue Hoche, 30029 Nîmes, Cedex 4, France.
Ropivacaine is less potent and less toxic than bupivacaine. We administered these two local anesthetics in a cardiac electrophysiologic model of sodium thiopental-anesthetized and ventilated piglets. After assessing the stability of the model, bupivacaine (4 mg/kg) and ropivacaine (6 mg/kg) were given IV in two groups (n = 7) of piglets. No alteration in biological variables was reported throughout the study. Bupivacaine and ropivacaine similarly decreased mean aortic pressure from 99 ± 22 to 49 ± 31 mm Hg and from 87 ± 17 to 58 ± 28 mm Hg, respectively, and decreased the peak of the first derivative of left ventricular pressure from 1979 ± 95 to 689 ± 482 mm Hg/s and from 1963 ± 92 to 744 ± 403 mm Hg/s, respectively. Left ventricular end-diastolic pressure was similarly increased from 6 ± 5 to 9 ± 5 mm Hg and from 6 ± 4 to 12 ± 4 mm Hg, respectively. Bupivacaine and ropivacaine similarly lengthened the cardiac cycle length (R-R; from 479 ± 139 to 706 ± 228 ms and from 451 ± 87 to 666 ± 194 ms, respectively), atria His (from 71 ± 15 to 113 ± 53 ms and from 64 ± 6 to 86 ± 10 ms, respectively), and QTc (QTc = QT x R-R-0.5, Bazett formula; from 380 ± 71 to 502 ± 86 ms and from 361 ± 33 to 440 ± 56 ms, respectively) intervals. Bupivacaine altered to a greater extent the PQ (the onset of the P wave to the Q wave of the QRS complex) (from 97 ± 20 to 211 ± 60 ms versus from 91 ± 8 to 145 ± 38 ms, P < 0.05), QRS (from 58 ± 3 to 149 ± 34 ms versus from 60 ± 5 to 101 ± 17 ms, P < 0.05), and His ventricle interval (from 25 ± 4 to 105 ± 30 ms vs from 25 ± 4 to 60 ± 30 ms, P < 0.05) than ropivacaine. A 6 mg/kg ropivacaine dose induced similar hemodynamic alterations as 4 mg/kg bupivacaine. However, bupivacaine altered the variables of ventricular conduction (QRS and His ventricle) to a greater extent.
IMPLICATIONS: A 6 mg/kg ropivacaine dose induced similar hemodynamic alterations as 4 mg/kg bupivacaine. However, bupivacaine altered the variables of ventricular conduction (QRS and His ventricle) to a greater extent.
This article has been cited by other articles:
![]() |
S. E. Copeland, L. A. Ladd, X.-Q. Gu, and L. E. Mather The Effects of General Anesthesia on the Central Nervous and Cardiovascular System Toxicity of Local Anesthetics Anesth. Analg., May 1, 2008; 106(5): 1429 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Stehr, T. Christ, B. Rasche, S. Rasche, E. Wettwer, A. Deussen, U. Ravens, T. Koch, and M. Hubler The Effects of Levosimendan on Myocardial Function in Ropivacaine Toxicity in Isolated Guinea Pig Heart Preparations Anesth. Analg., September 1, 2007; 105(3): 641 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. D. Mayr, C. Raedler, V. Wenzel, K. H. Lindner, and H.-U. Strohmenger A Comparison of Epinephrine and Vasopressin in a Porcine Model of Cardiac Arrest After Rapid Intravenous Injection of Bupivacaine Anesth. Analg., May 1, 2004; 98(5): 1426 - 1431. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Weinberg, C. Paisanthasan, D. Feinstein, and W. Hoffman The Effect of Bupivacaine on Myocardial Tissue Hypoxia and Acidosis During Ventricular Fibrillation Anesth. Analg., March 1, 2004; 98(3): 790 - 795. [Abstract] [Full Text] [PDF] |
||||
|